On the other hand, it upregulates p-AMPKα levels, regulating glucolipid metabolism and ameliorating liver injury, insulin resistance, glucose tolerance, lipid accumulation, and inflammation in NAFLD mice [102]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.